BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32854639)

  • 1. Association of HIV infection with clinical and laboratory characteristics of sickle cell disease.
    Belisário AR; Blatyta PF; Vivanco D; Oliveira CDL; Carneiro-Proietti AB; Sabino EC; de Almeida-Neto C; Loureiro P; Máximo C; de Oliveira Garcia Mateos S; Flor-Park MV; de Oliveira Werneck Rodrigues D; Afonso Mota R; Gonçalez TT; Hoffmann TJ; Kelly S; Custer B;
    BMC Infect Dis; 2020 Aug; 20(1):638. PubMed ID: 32854639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE; Nevitt SJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium.
    Masese RV; Bulgin D; Knisely MR; Preiss L; Stevenson E; Hankins JS; Treadwell MJ; King AA; Gordeuk VR; Kanter J; Gibson R; Glassberg JA; Tanabe P; Shah N;
    PLoS One; 2021; 16(10):e0258638. PubMed ID: 34714833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between sickle cell disease and HIV infection: a systematic review.
    Owusu ED; Visser BJ; Nagel IM; Mens PF; Grobusch MP
    Clin Infect Dis; 2015 Feb; 60(4):612-26. PubMed ID: 25344542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease.
    Tozatto-Maio K; Girot R; Ly ID; Silva Pinto AC; Rocha V; Fernandes F; Diagne I; Benzerara Y; Dinardo CL; Soler JP; Kashima S; Araujo IL; Kenzey C; Fonseca GHH; Rodrigues ES; Volt F; Jarduli L; Ruggeri A; Mariaselvam C; Gualandro SFM; Rafii H; Cappelli B; Nogueira FM; Scigliuolo GM; Guerino-Cunha RL; Malmegrim KCR; Simões BP; Gluckman E; Tamouza R
    Front Immunol; 2020; 11():2041. PubMed ID: 33013863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell disease is associated with decreased HIV but higher HBV and HCV comorbidities in U.S. hospital discharge records: a cross-sectional study.
    Nouraie M; Nekhai S; Gordeuk VR
    Sex Transm Infect; 2012 Nov; 88(7):528-33. PubMed ID: 22628662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.
    Kourtis AP; Bansil P; Johnson C; Meikle SF; Posner SF; Jamieson DJ
    Pediatr Infect Dis J; 2007 May; 26(5):406-10. PubMed ID: 17468650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.
    Cintho Ozahata M; Page GP; Guo Y; Ferreira JE; Dinardo CL; Carneiro-Proietti ABF; Loureiro P; Mota RA; Rodrigues DOW; Belisario AR; Maximo C; Flor-Park MV; Custer B; Kelly S; Sabino EC;
    J Sex Med; 2019 Dec; 16(12):1988-1999. PubMed ID: 31668730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HIV risks in a Brazilian sickle cell disease population.
    Blatyta PF; Kelly S; Goncalez TT; Carneiro-Proietti AB; Salomon T; Miranda C; Sabino E; Preiss L; Maximo C; Loureiro P; Custer B; de Almeida-Neto C;
    BMC Public Health; 2020 Oct; 20(1):1606. PubMed ID: 33097032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of sociodemographic, clinical, and laboratory markers of sickle leg ulcers among young nigerians at a tertiary health institution.
    Olatunya OS; Albuquerque DM; Adekile AD; Costa FF
    Niger J Clin Pract; 2018 Jul; 21(7):882-887. PubMed ID: 29984720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between glutathione S-transferase genes (GSTM1, GSTT1, and GSTP1) polymorphisms and clinical manifestations of sickle cell disease in Egyptian patients.
    Ellithy HN; Yousri S; Shahin GH
    Hematology; 2015 Dec; 20(10):598-606. PubMed ID: 25880856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children with HbSβ
    Day ME; Rodeghier M; DeBaun MR
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27352. PubMed ID: 30094930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
    Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC
    Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.